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A tetrazole ring is often used in drug discovery as a replacement for the carboxylic acid 
group.  Previous work indicates that compounds containing a tetrazole moiety show 
asymmetric permeability in Caco-2 cells characteristic of an efflux transporter substrate.  
The aim of this study is to determine which transporters are responsible for polarization 
of transport of tetrazole containing compounds in Caco-2 cells.  Results indicate that only 
select compounds with tetrazole moieties display asymmetric transport.  Three 
compounds (two commercial drug products and one drug-like structure) were selected for 
further studies.  Losartan appears to be primarily a P-glycoprotein (P-gp) substrate, as 
previously reported, but MRP inhibitors such as MK-571 and rifampicin also affect the 
difference between apical to basolateral and basolateral to apical transport.  Pemirolast 
and phenyltetrazole derivative C are sensitive to P-gp inhibition, but transport seems to 
be mediated by one or more of the MRP family of transporters.  Additionally, lowering 
the pH from 7.4 to 4.0 eliminates the polarization of permeability in Caco-2 cells.  These 
studies indicate that some tetrazole compounds are susceptible to efflux, therefore caution 
should be used when choosing an appropriate functional group to replace carboxylic 
acids when synthesizing a drug candidate. 
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  One major consideration when developing a drug candidate is the potential for 
interactions with cellular efflux transporters.  One such transporter, P-glycoprotein (P-gp) 
has been shown to significantly decrease the intestinal absorption of numerous 
compounds.1  An accurate screening method early in the drug discovery/development 
process that can detect which candidates are susceptible to P-gp efflux is a highly 
valuable tool.1,2 
  The Caco-2 assay, using cells derived from a human adenocarcinoma is widely used 
to assess intestinal permeability, and results from this in vitro system compare favorably 
with in vivo and in situ data.3,4  The apically (luminally) located P-gp is expressed and 
active in Caco-2 cells, therefore the cell line is employed to evaluate whether a drug 
candidate is a substrate for this transporter.5 
  Previous studies in our laboratories have shown that drug-like molecules with 
particular chemical groups often used to improve a drug candidate’s physicochemical 
properties can exhibit polarized transport properties that are characteristic of efflux pump 
substrates.6  In particular, benzoic acid, amidine, and tetrazole moieties conferred high 
basolateral to apical permeability compared to apical to basolateral permeability, 
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suggesting contributions of polarized transport mechanisms.  We have selected tetrazole-
containing compounds to study because they showed the highest degree of polarization.6 
Losartan, an angiotensin II antagonist containing a tetrazole ring (Figure 1), has been 
shown to be a P-gp substrate.7-9  Its poor oral absorption can at least partially be 
attributed to its affinity for P-glycoprotein, however it appears that other transporters may  
Young, A.M., Audus, K.L., Proudfoot, J., and Yazdanian, M. (2006) Tetrazole compounds: The effect of structure and 
charge on Caco-2 permeability.  J. Pharm. Sci. 95, 717-725.  PMID: 16498570.  Publisher’s official version: 


















































 Pemirolast    A    B 
 

















                                                             
  C D E  
 
Figure 1:  Structures of selected compounds  
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also be responsible for asymmetric transport of losartan in Caco-2 cells.8  Structurally 
related angiotensin II antagonists show a wide variability in bioavailability that suggests a 
difference in efflux transporter affinity among the structures.9 
  In this study, currently marketed drugs as well as a selection of synthesized “drug-
like” compounds were used to assess the effect of structure and charge on Caco-2 cell 
permeability for molecules containing a tetrazole moiety. 
 
Materials:  
Dulbecco’s Modified Eagle’s Medium (DMEM) buffered with HEPES, heat-inactivated 
fetal bovine serum, non-essential amino acids, and penicillin-streptomycin were obtained 
from Gibco Invitrogen (Carlsbad, CA). Losartan, valsartan, irbesartan, and cilostazol 
were purchased from Sequoia Research Products, Ltd. (Oxford, UK).  MK-571 was 
obtained from Biomol Laboratories (Plymouth Meeting, PA).  Transwell plates were 
from the Costar Corporation (Acton, MA). 14C Mannitol was obtained from Perkin Elmer 
(Boston, MA).  Pemirolast and compounds A through E were synthesized by the 
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) Medicinal Chemistry Department. 
Caco-2 cells were acquired from ATCC (Manassas, VA).  MDCK and MDCK-MDR1 
cells were provided by the NIH (Bethesda, MD).  All other chemicals were purchased 
from Sigma Chemical Company (St. Louis, MO).Cell Culture  
Caco-2 cells were grown at 37°C, 90% RH and 5% CO2.  DMEM was buffered with 
HEPES and supplemented with penicillin-streptomycin (10,000 units/mL), non-essential 
amino acids (10 mM) and 10% heat-inactivated fetal bovine serum. Cells were grown in 
Transwell plates (12 well, 1.12 cm2 surface area, 0.4 µm pore size) and used for 
experiments from days 21 to 25.  MDCK and MDCK-MDR1 cells were grown using the 
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same culture conditions listed above.  Medium was prepared in the same way as Caco-2, 
except that colchicine (20 µg/mL) is added for culturing the MDR1 transfected cells.  
Cells were grown in Transwell plates for permeability studies.  They were used five 
days post seeding. 
Permeability Studies: 
 Cells were washed with HBSS with or without inhibitor and equilibrated at experimental 
conditions (4° or 37° C) for 30 minutes.  Drug with or without inhibitor was loaded into 
either the apical or basolateral compartment.  Plates were shaken (100 rpm) at 
experimental conditions, and sampled every thirty minutes for two or three hours 
depending on the permeability of the compound.  Samples were taken from the receiver 
compartment (300 µL) at each time point and replaced with fresh HBSS with or without 
inhibitor.  For the sodium dependence studies, sodium free salt solution replaced sodium 
chloride with choline chloride and pH was adjusted with tetramethylammonium 
hydroxide.10  The studies at pH=4 were performed in HBSS buffered with 20 mM sodium 
acetate.  The inhibitor concentrations used were as follows:  5 µM for Cyclosporin A, 50 
µM for MK-571, and 100 µM for rifampicin, SBP, and CCCP.  The concentration of test 
compounds was either 100 µM or a saturated solution in HBSS (whichever concentration 
is lower). 
LC and LC/MS Detection: 
Samples were analyzed using HPLC with an Agilent LC/MSD 1100 instrument.  A 
Zorbax C18 column (4.6 x 150 mm) was used for the LC separation.  Some compounds 
were analyzed using UV detection, while others were analyzed with mass spectrometry 
(electrospray ionization;single quadrupole). 
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Liquid Scintillation Counting: 
14C Mannitol flux was detected using a Tri-Carb 2700TR liquid scintillation counter. 
Permeability Calculations: 
Apparent permeability (Papp) in cm/sec was calculated using the following equation:      
Papp = dC/dt *Vr/A*Cd 
 
dC/dt is the change in concentration in the receiver compartment over time, Vr is the 
receiver compartment volume, A is the area of the polycarbonate membrane and Cd is the 
initial donor compartment concentration. The PDR, or permeability directional ratio, is a 
measure of polarization of the compound in Caco-2.  The following equation determined 
the ratio: 
 
PDR = PB to A / P A to B 
 
Statistical Analysis:  
Student’s t test was used to determine the statistical significance. A p value less than 0.05 




 Figure 1 shows the structures of drug-like molecules selected for study.  Losartan, 
valsartan, and cilostazol are commercially available compounds that contain a tetrazole 
ring.  Pemirolast, and compounds A-E were synthesized in our laboratories for 
comparative purposes. To determine the structural effects of the tetrazole ring, a 
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carboxylic acid (A) and a nitrile (B) analogue of pemirolast were synthesized.  
Additionally, analogues D and E of the previously studied phenyltetrazole C were 
evaluated to determine the importance of the tetrazole ring for efflux properties.6 
Caco-2 Cell Permeabilities: 
 Apical to basolateral (A to B) and basolateral to apical (B to A) permeability 
values for each of the chosen molecules are given in Table 1.   A PDR that exceeded 2 
was considered a significant enough difference to warrant further study.  Losartan, 
pemirolast and compound C all fit this criterion.  Additional Caco-2 cell permeability 
studies were performed to determine whether the presence of inhibitors of various efflux 
transporters affected the PDR of each drug or drug-like molecule. 
Losartan: 
 Caco-2 cell permeability values were evaluated in the presence of several 
inhibitors to determine the type of efflux transporters involved (Table 2).  Lowering the 
temperature to 4°C essentially eliminates A to B  and B to A transport as compared to the 
control (0.38 x 10-6 and 3.3 x 10-6 cm/sec, respectively).  CCCP (carbonyl cyanide 3-
chlorophenyl hydrazone), a metabolic inhibitor, had no significant effect on PDR.  
Although the ratio remained the same, the A to B and B to A permeability values  
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increased over two fold.  When a sodium free medium was used in place of HBSS, the 
PDR increased dramatically  
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from 6.0 to 25.4 (A to B permeability decreased by two fold and B to A permeability 
increased by two fold).  Basolateral to apical permeability decreased approximately ten 
fold in the presence of cyclosporin A (5 µM), lowering the PDR to 0.6.  MRP inhibitor 
MK-571 and MRP/OATP inhibitor rifampicin also affected the PDR of losartan 
considerably (6.0 for control and 0.7 with rifampicin). Exposure of Caco-2 cells to 100 
µM sulfobromopthalein (SBP), an OATP inhibitor, did not alter permeability values as 
compared to the control. 
Pemirolast: 
 Permeability values for pemirolast and its carboxylic acid and nitrile analogues, 
compounds A and B are shown in Table 1.  Pemirolast has a PDR of 5.7, and A and B 
both have PDRs of 1.0.  Table 3 includes pemirolast permeability studies performed with 
the same inhibitors used for losartan.  In this case, reducing the temperature to 4°C 
significantly diminished the A to B and B to A permeabilities.  Both were lowered over 
20 fold from control values, and the PDR was calculated to be 7.6.  Addition of CCCP 
changed the PDR to 1.0, thereby eliminating any polarization of permeability.  A sodium 
free buffered saline solution reduced the PDR slightly to 3.5, but B to A permeability still 
exceeded A to B.   
 P-gp inhibitor cyclosporin A decreased the PDR significantly as did the MRP 
inhibitors MK-571 and rifampicin (1.5, 1.2 and 1.3, respectively).  In addition, SBP 
decreased the PDR nearly two fold from 5.7 to 3.0. 
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Compound C (1-[3-(2H-Tetrazol-5-yl)-benzyl]-1H-benzoimidazole) 
 One of the drug-like molecules synthesized in our labs showed the highest PDR 
of any of those screened (Table 1), with a 66.1 fold higher B to A permeability as 
compared to A to B.6  In contrast, closely related structural analogues compounds D and 
E have PDRs of only 1.1 and 2.2, respectively.  By reducing the temperature to 4°C, the 
B to A permeability of compound C is lowered dramatically from 6.0 x 10-6 cm/sec to 0.7 
x 10-6 cm/sec (Table 4).  The PDR decreased considerably, but B to A permeability is still 
seven fold higher than A to B.  Permeability of compound C in the presence of CCCP is 
diminished even further to a PDR of 3.8.  The absence of sodium resulted in a large 
increase in B to A transport and a significantly higher PDR of 7133. 
Cyclosporin A caused an increase in B to A permeability and a reduction in A to 
B permeability that resulted in a modest decrease in the PDR (from 66.1 to 52.2).  MK-
571 effectively eliminated polarized permeability of benzimidazole compound C by 
lowering the PDR to 0.8.  Rifampicin significantly decreased the PDR to 12.5, while SBP 
exposure produced an insignificant change in the PDR (from 66.1 to 47). 
MDCK and MDCK-MDR1 permeabilities: 
 To determine whether any of polarized permeability observed was due to P-gp, 
the MDR1 transfected MDCK cell line was employed (Table 5).  PDRs for all three 
selected compounds in the wild type MDCK cells were approximately 1.  MDCK-MDR1 
permeability values differed depending on the particular compound.  Losartan 
permeability could not be detected in the A to B direction, but it was  
significantly higher from B to A (1 x 10-5 cm/sec).  Pemirolast permeability in transfected 
cells is three fold higher from B to A as compared to A to B, a significant increase in  
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PDR as compared to wild type (3.0 and 0.43, respectively).  Compound C has a PDR of 
1.3 for both wild type and transfected cells. 
 
Permeability at pH=4.0 
Caco-2 cell permeability was measured at pH=4.0 to determine whether 
compound charge had any effect (Table 6).  Losartan, Pemirolast, and benzimidazoles C 
and D all had PDRs of approximately 1. 
 
Monolayer Integrity in the Presence of Inhibitors 
 Paracellular permeability was measured with radiolabeled mannitol for each of 
the inhibitors used to confirm that they do not affect the integrity of the monolayer.  None 
of the inhibitors or media used (pH=4.0 and sodium free buffer) caused a significant 
increase in paracellular permeability when compared to control (Table 7).  Additionally, 
Table 8 shows the permeability of marker compounds caffeine and lucifer yellow in 
Caco-2 cells (Table 8).  There appears to be no significant difference between the values 
at pH 7.4 and 4.0. 
Discussion and Conclusions 
 The studies presented here show that not all tetrazole-containing compounds are 
asymmetrically transported in Caco-2 cells (Table 1).    Valsartan, irbesartan, cilostazol 
and benzimidazole D do not show a significant difference between A to B and B to A 
permeability.  Literature results confirm that cilostazol is not subject to significant 
polarization of transport.  Toyobuku and colleagues recently reported that although 
cilostazol was subject to efflux in cells overexpressing P-gp, the transporter has little  
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effect on in situ intestinal absorption because of a countering apical uptake mechanism.11  
Three of the compounds studied (losartan, pemirolast and benzimidazole C) had PDRs 
greater than 2 that warranted further investigation in to what efflux transporters are 
involved in their asymmetric transport. 
 Losartan is well established as a P-gp substrate in the literature.8-10  Rose and 
Audus reported that losartan and other angiotensin II antagonists act as P-gp substrates in 
the blood-brain endothelial barrier.7  Soldner and colleagues assert that most of the 
polarization of losartan in Caco-2 is due to P-gp, however another transporter must also 
be involved.8 
 Our work confirms that losartan is a substrate of P-gp.  The PDR is reduced 
substantially in the presence of cyclosporin A (Table 2), and the MDR1 transfected cell 
line shows significant B to A permeability and no detectable permeability in the A to B 
direction.  There was likely some permeability from the apical to basolateral 
compartments, but it fell below the limits of UV detection for the chosen HPLC method.  
Cyclosporin A has been shown to inhibit transporters in addition to P-gp (e.g., MRP7), 
therefore the resulting PDR maybe not be entirely due to P-gp inhibition.12    
Additionally, the MRP inhibitors MK-571 and rifampicin were able to inhibit 
efflux pump activity in Caco-2 cells.  The MRP family of transporters is not fully 
characterized, and little is known regarding the substrate specificity of each isoform.  
Both inhibitors are known to affect MRP1 and MRP2, but it is likely that other MRPs 
could be affected by these compounds.  Soldner et al. used MRP1 and MRP2 transfected 
MDCK cells to demonstrate that losartan efflux was not mediated by these transporters.8  
Our work does not directly contradict these findings.  Rather, we assert that other MRP 
transporters may be responsible for asymmetric losartan transport in the Caco-2 cell line.  
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Recent work by Prime-Chapman and colleagues shows the expression of MRP 1 through 
6 in Caco-2 cells.  The differences in functional activity between isoforms has not yet 
been clarified.13 
 Pemirolast, another currently marketed pharmaceutical, shows a polarization of 
permeability in Caco-2 cells.  The low PDR values for compounds A and B (structural 
analogues of pemirolast) indicate a clear structure-activity relationship. Both carboxyl 
(A) and nitrile (B) analogues have equal A to B and B to A permeability values.  It seems 
that the tetrazole moiety is responsible for the polarization of permeability in the drug 
molecule.  
Pemirolast also appears to be a substrate for P-glycoprotein and at least one of the 
MRP isoforms.   As described earlier, the specificity of the MRP inhibitors is unknown, 
therefore the particular isoform cannot be directly identified.  Asymmetric transport in 
the presence of cyclosporin A was decreased significantly, although not completely 
(Table 3).  The MDCK studies show a threefold greater B to A permeability as compared 
to A to B in the MDR1 transfected cell line.  It is important to note that the PDR for the 
wild type MDCK is 0.43, indicating that A to B transport exceeds B to A by more than 
twofold (Table 5).  Although untransfected MDCK cells are generally believed to lack 
most efflux transporters, Ng and colleagues have found MRP2-like and OATP2-like 
transport activity of organic anions in wild type MDCK cells.14  It is possible that 
pemirolast is a substrate of a transporter not found in Caco-2 cells. 
 MRP inhibitors effectively decreased the permirolast PDR to 1 in Caco-2 cells.  
The addition of sulfobromopthalein (SBP), an OATP  inhibitor, reduced the PDR from 
5.7 to 3.0, though not to a significant extent. 
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 Benzimidazole compound C showed the most dramatic difference between A to B 
and B to A permeability (PDR = 66.1).  Like pemirolast, it seems that the tetrazole ring is 
the portion of the structure primarily responsible for the differences in directional 
permeability.  Compound E, the carboxylic acid analogue of C, has a PDR of 2.2.  This is 
consistent with previous findings in our lab, showing asymmetric transport with tetrazole 
and carboxyl containing compounds.6  Inhibition of active transport (4°C and CCCP) 
reduced the PDR to 7.0 and 3.8, respectively, suggesting both active and 
passive/facilitative transport mechanisms.  Sodium free medium actually increased the 
PDR quite significantly, thereby removing facilitative transporters such as OATP from 
consideration. 
 Inhibition of P-gp via cyclosporin A results in a small decrease in polarization of 
compound C, indicating that this transporter is not the primary cause of the asymmetry of 
transport.  MK-571 effectively eliminates any differences between A to B and B to A 
permeability, while the less-specific rifampicin lowers the PDR from 66.1 to 12.5.  SBP 
exposure produces little change in the polarization of transport (Table 4). 
 Aside from efflux transporters, another main consideration is the effect of pH and 
ionization of the compounds on permeability.  The pKa of tetrazoles is in the range of 4-
5, similar to that of carboxylic acid groups.9  Therefore, the structures should be 
considered negatively charged at experimental conditions (pH 7.4).  One notable 
exception is benzoimidazole compound D, which is attached to the rest of the molecule 
via a nitrogen as compared to a carbon.  As a result, the tetrazole ring is uncharged at pH 
values in the physiological range.  Comparing the PDRs of the two compounds in Caco-2 
cells show the startling difference between the two (66.1 for C and 1.1 for D).   
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 Caco-2 cell permeability studies were performed at pH 4.0 to determine the effect 
of charge.  Surprisingly, all of the compounds showing asymmetric permeability values at 
7.4 showed no differences in permeability at acidic conditions.  Compounds C and D 
both had PDRs of 1.  At pH 4.0, the permeability in both directions increased 
significantly (Table 6) for all compounds except benzimidazole D. This is reasonable 
because all the compounds studied with the exception of D go from negatively charged to 
neutral, therefore passive diffusion across the plasma membrane is much more favorable.  
Compound D is neutral under all the experimental conditions, so the passive permeability 
should not be altered.  Literature results have demonstrated that a higher fraction of 
charged species reduces Caco-2 cell permeability.15  Our mannitol studies (Table 7) 
confirm that pH= 4.0 media does not increase the paracellular permeability and thereby 
artificially increase the numbers during the course of the experiment.  As an additional 
control, the high and low permeability markers (caffeine and lucifer yellow, respectively; 
Table 8) showed no difference in permeability when the media was pH 7.4 or 4.0. 
 Little is known about the effect of pH on the efflux transporters themselves. One 
explanation of the data at pH = 4.0 is that the functional activity of the transporters is 
impaired at the experimental conditions.  Additional studies at pH = 4.0 with known 
transporter substrates would help to clarify the matter.  The pH of the gastrointestinal 
tract can vary depending on diet and disease state (typically from 5 to 8), therefore is 
important to recognize the possibility of a pH dependent variability of absorption. A more 
realistic representation of the in vivo situation would be to study drug transport with a 
range of pH values in the apical compartment, while keeping the basolateral compartment 
value a constant pH 7.4.16 
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 This work demonstrates that certain tetrazole compounds are efflux transporter 
substrates.  All the selected compounds screened in this work seem to have an interaction 
with a member of the MRP family.  The particular isoform is not known due to substrate 
overlap and prior work that indicates that losartan efflux is not MRP1 or MRP2 
mediated.8  To an extent, losartan and pemirolast also show some interaction with P-gp.  
In this case, interaction with the relevant transporter(s) seems to be based on the tetrazole 
structure recognition as well as the negative charge at physiological pH.   
 This paper also raises some concerns about the use of tetrazole groups as a 
replacement for carboxylate groups during the lead optimization process.  Data presented 
here suggest that this substitution could significantly affect the efflux transporter affinity, 
and therefore the absorption and bioavailability of the candidate.   
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